Provided by Tiger Trade Technology Pte. Ltd.

Reneo Pharmaceuticals, Inc.

18.20
0.0000
Volume:- -
Turnover:794.64K
Market Cap:60.84M
PE:-10.81
High:18.20
Open:18.20
Low:18.20
Close:18.20
52wk High:18.20
52wk Low:0.9801
Shares:3.34M
Float Shares:1.10M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6843
EPS(LYR):-2.5227
ROE:-54.00%
ROA:-33.72%
PB:0.79
PE(LYR):-7.21

Loading ...

BRIEF-Onkure Announces Closing Of Merger With Reneo Pharmaceuticals And Concurrent Private Placement Of $65 Million

Reuters
·
Oct 05, 2024

Onkure Announces Closing of Merger With Reneo Pharmaceuticals and Concurrent Private Placement of $65 Million

THOMSON REUTERS
·
Oct 05, 2024

Reneo Pharmaceuticals Inc: Expected Funding Runway Into Q4-2026

THOMSON REUTERS
·
Oct 05, 2024

Reneo Pharmaceuticals Inc: on Track to Announce Early Clinical Data for Lead Program in Q4-2024

THOMSON REUTERS
·
Oct 05, 2024

OnKure Announces Closing of Merger with Reneo Pharmaceuticals and Concurrent Private Placement of $65 Million

GlobeNewswire
·
Oct 05, 2024

Reneo Pharmaceuticals' Shareholders Approve Merger With OnKure; Reverse Stock Split Imminent

MT Newswires Live
·
Oct 03, 2024

BRIEF-Reneo Pharmaceuticals Announces Stockholder Approval Of Merger With Onkure

Reuters
·
Oct 03, 2024

Reneo Pharmaceuticals Announces Stockholder Approval of Merger With Onkure

THOMSON REUTERS
·
Oct 03, 2024

Reneo Pharmaceuticals Inc - Combined Company to Trade on Nasdaq Under Ticker 'Okur'

THOMSON REUTERS
·
Oct 03, 2024

Reneo Pharmaceuticals Inc - Announces 1-for-10 Reverse Split of Common Stock

THOMSON REUTERS
·
Oct 03, 2024

Reneo Pharmaceuticals Announces Stockholder Approval of Merger with OnKure

GlobeNewswire
·
Oct 03, 2024

Reneo Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

Reuters
·
Aug 13, 2024

Reneo Pharmaceuticals Q2 2024 GAAP EPS $(0.16) Up From $(0.65) YoY

Benzinga
·
Aug 13, 2024

BRIEF-Reneo Pharmaceuticals Q2 EPS USD -0.16

Reuters
·
Aug 13, 2024